Mental Health in the Workplace Series

Depression, anxiety, and substance abuse can result in interpersonal conflict, workplace violence, reduced productivity, lost work time, and many other problems. This webinar symposium series will cover different topics biannually.

October 19, 2022: Substance Use and Addiction in the Workplace: Implications for Interventions

 

Presenters:

Stuart Gitlow, MD, MPH, MBA
Board Certified in Psychiatry, Forensic Psychiatry, and Addiction Medicine
Past President of the American Society of Addiction Medicine

Dr. Gitlow, Immediate Past President of the ASAM Board of Directors, is an Aviation Medical Examiner specializing in addiction and psychiatric issues for the Federal Aviation Administration. He served in the past as Chair of the AMA’s Council on Science and Public Health. Dr. Gitlow serves as ASAM’s delegate to the AMA. Board certified in general, addiction, and forensic psychiatry, Dr. Gitlow has an active addiction medicine practice. Graduate of MIT and Mount Sinai School of Medicine, Dr. Gitlow’s psychiatric and public health training took place in Pittsburgh, following which he went to Harvard for his forensic fellowship. Dr. Gitlow formerly produced both Health Channel and ABC programming at America Online.

Timothy W. Fong, MD
Psychiatrist at Resnick Neuropsychiatric Hospital, Professor at UCLA Semel Institute for Neuroscience, UCLA Gambling Studies Program, UCLA Cannabis Research Initiative

Dr. Fong is a Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA and he is board certified in adult and addiction psychiatry. He is the co-director of the UCLA Gambling Studies Program. The purpose of this program is to examine the underlying causes and clinical characteristics of gambling disorder in order to develop effective, evidence-based treatment strategies. Dr. Fong is also part of the Steering Committee of the UCLA Cannabis Research Initiative whose mission is to address the most pressing questions related to the impact of cannabis legalization through rigorous scientific study and discourse across disciplines. Clinically, he is the Director of the UCLA Addiction Psychiatry Consultation Service and is an Attending Physician in the UCLA Addiction Psychiatry Clinic and the Breathe Well, Be Well program.

Agenda

10:00 – 10:05am : Welcome, Introductions, Overview | Dr. Ed Alvino, Dr. Taha Ahmad, Dr. Pouran Faghri

10:05 – 10:45 : Dr. Stuart Gitlow: “Substance Use - Order or Disorder?”

10:45 – 11:25 : Dr. Timothy Fong: "Practical Solutions on Addressing Substance Use in the COVID-World Workplace"

11:25 – 11:55 : Q&A Moderators – Dr. Ed Alvino, Dr. Taha Ahmad, Dr. Pouran Faghri

11:55 – 12:00pm : Closing Remarks

 

Presentations:

Dr. Stuart Gitlow: “Substance Use - Order or Disorder?”

Learning Objectives - Healthcare Providers and Physicians will be able to:

  1. Differentiate among occasional substance use, unhealthy substance use, and addictive disease
  2. Identify strategies to detect impairment at the workplace related to substance use
  3. Recognize the limitations and restrictions that can arise in the workplace from substance use
  4. Utilize patient engagement strategies to enhance compliance with evidenced-based substance use evaluations and treatments
  5. Promote return to function in patients impaired from substance use, as compatible with the patient’s health and safety in the workplace

Dr. Timothy Fong: "Practical Solutions on Addressing Substance Use in the COVID-World Workplace"

Goals and Objectives

  1. Name three consequences of COVID-19 on the impact of substance use for individuals working from home
  2. Promote acceptable workplace behaviors through implementation of drug/alcohol testing
  3. Implement appropriate substance-free policies at the workplace and understand the steps involved in dealing with non-compliance
  4. Recommend valuable information for educating employees about substance use consequences and how a substance-free workplace is supportive to health and wellness
  5. Review current federal and state of California policies regarding cannabis use in the workplace (in-person or for those working from home)

 

Other Session Learning Objectives

  1. Name three consequences of COVID-19 on the impact of substance use for individuals working from home
  2. Describe the relationship between psychoactive substance use and workplace impairment, recognizing that not all substance use may lead to workplace impairment or difficulties
  3. Promote acceptable workplace behaviors through implementation of drug/alcohol testing
  4. Implement appropriate substance-free policies at the workplace and understand the steps involved in dealing with non-compliance
  5. Recommend valuable information for educating employees about substance use consequences and how a substance-free workplace is supportive to health and wellness
  6. Review current federal and state of California policies regarding cannabis use in the workplace (in-person or for those working from home)

 


Series Overview:

Depression, anxiety, and substance abuse can result in interpersonal conflict, workplace violence, reduced productivity, lost work time, and many other problems. This webinar series will cover different topics biannually.

Expect topics on:

  • How productivity is affected by mental health and how to promote mental health in the workplace
  • Recognizing behavioral health impairments and promoting a healthy degree of focus in the workplace
  • Lifestyle factors that influence behavioral health
  • Overcoming COVID-19 related anxieties
  • Mental Health on work impairment among nurses during the COVID-19 crisis
  • Early recognition and appropriate related therapy to maintain productivity in the workplace
  • Employer and employee rights
  • And much more!

This webinar series will:

  • Define the scope and the impact of behavioral health conditions in the workplace.
  • Explain the extent to which behavioral health conditions compromise an employee’s productivity, absenteeism, and cost.
  • Discuss the behavioral health conditions that most commonly contribute to issues in the workplace.
  • Evaluate utilization of psychotherapy and psychopharmacology in the outlined patient population.
  • Present programs that have successfully addressed early, safe return to work, workplace health and safety, and appropriate accommodation.

Series Learning Objectives*

By the end of the sessions, participants should be able to:

  1. Describe the impact of behavioral health conditions on both the employer and the employee.
  2. Recognize behavioral health conditions that commonly limit an employee’s productivity.
  3. Summarize available programs shown to increase productivity and decrease absenteeism in employees with these conditions.
  4. Review the appropriate treatment that may promote the most appropriate, safe return to work.
  5. Formulate workplace accommodations that may facilitate and maintain a successful return to work/stay at work.

* Each presentation will have its learning objectives

Who Should Attend?

This activity is intended for physicians, physician assistants, nurses, nurse practitioners, industrial hygienists, safety professionals; and accommodations, disability and human resources specialists, employers, supervisors, union representatives and members of health and safety committees.

 

Symposium Planning Committee

Edward C. Alvino, MD, Chief Medical Officer, UNUM

Taha M. Ahmad MD, MPH, FACP, Chief of Service, Occupational Health Services
Kaiser Permanente Panorama City

Pouran D. Faghri, MD, MS, FACSM, Adjunct Professor, School of Public Health at University of California, Los Angeles

 


Previous sessions

Session 2 - April 27, 2022: Behavioral Factors of COVID-19 in the Workplace

 

Presenters:

Keith Caruso, MD, FAPA, Forensic Psychiatrist. Presentation:“Mental Health in the Workplace: COVID-19 and Psychiatric Disorders”

Learning Objectives:

  1. Identify high-risk groups and common diagnoses for COVID -19 pandemic related psychiatric illnesses.
  2. Identify psychiatric responses to mask and vaccine mandates.
  3. Identify the overall impact of the COVID-19 pandemic on mental health in the psychiatric patients and the general population.

Robert Bilder, PhD, ABPP-CN, UCLA Michael E. Tennenbaum Family Distinguished Professor of Psychiatry & Biobehavioral Sciences and Psychology; Chief, Division of Psychology; UCLA Geffen School of Medicine; Semel Institute for Neuroscience at UCLA; Resnick Neuropsychiatric Hospital at UCLA. Presentation: Dimensions of Psychological Well-Being in the Workplace: Life in the Time of COVID-19”

Learning Objectives:

  1. Describe at least two components of psychological well-being.
  2. Describe at least two ways to increase psychological well-being.
  3. State at least two ways that psychological well-being has been impacted by COVID-19.

Agenda

10:00 – 10:05am : Welcome, Introductions, Overview | Dr. Ed Alvino, Dr. Taha Ahmad, Dr. Pouran Faghri

10:05 - 10:45 : Keith Caruso, MD, F.A.P.A, Forensic & General Psychiatry

  • Mental Health in the Workplace: COVID-19 and Psychiatric Disorders

10:45 - 11:25 : Robert Bilder, PhD, Chief of Psychology and Distinguished Professor of Psychiatry * Biobehavioral Sciences and Psychology | UCLA Semel Institute for Neuroscience & Human Behavior

  • Dimensions of Psychological Well-Being in the Workplace: Life in the Time of COVID-19

11:25 - 11:55 : Q&A Moderators – Dr. Ed Alvino, Dr. Taha Ahmad, Dr. Pouran Faghri

11:55 - 12:00 : Closing Remarks


Session 1 - September 21, 2021: Optimizing Mental Health in the Workplace

 

Presenters:

Karen Miotto, MD, Professor of Clinical Psychiatry, University of California Los Angeles; Chair, UCLA Physician Wellness Program and Medical Staff Health Committee

Robert C. Larsen, MD, MPH, Director, Center for Occupational Psychiatry, Oakland, CA & Retired, Clinical Professor of Psychiatry, UCSF School of Medicine

 

Agenda:

10:00 – 10:05 am : Welcome, Introductions, Overview | Dr. Ed Alvino & Dr. Taha Ahmad

10:05-10:45 : Karen Miotto, MD, Professor of Clinical Psychiatry, University of California Los Angeles

  • Mental Health in the Workplace: Presentations and System Solutions

10:45-11:25 : Robert C. Larsen, MD, MPH, Director, Center for Occupational Psychiatry

  • Wounded Workers: Victims, Victors & the Very Fortunate

11:25-11:55 : Q&A Moderator(s) – Dr. Ed Alvino & Dr. Taha Ahmad

11:55-12:00 : Closing Remarks

 

Learning Objectives:

Upon completion of the course, participants should be able to:

  • Identify common mental health disorders in the workplace
  • Define evidence-based approaches to improving employee mental health
  • Explain tactics for leading multiple generations in the workplace
  • Identify a range of human responses that include victimization but also post-traumatic growth, resilience rather than impairment, forced adaptation in the difficult/impaired employee, and unexpected positive outcomes brought forth by selective advocacy.

 


Other Registration Options

Register by phone: 310-206-2304 

Email Us: lmlorenzana@ucla.edu, erc@ph.ucla.edu